These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

738 related articles for article (PubMed ID: 33774537)

  • 1. Antisuicidal and antidepressant effects of ketamine and esketamine in patients with baseline suicidality: A systematic review.
    Siegel AN; Di Vincenzo JD; Brietzke E; Gill H; Rodrigues NB; Lui LMW; Teopiz KM; Ng J; Ho R; McIntyre RS; Rosenblat JD
    J Psychiatr Res; 2021 May; 137():426-436. PubMed ID: 33774537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Esketamine Nasal Spray for Rapid Reduction of Major Depressive Disorder Symptoms in Patients Who Have Active Suicidal Ideation With Intent: Double-Blind, Randomized Study (ASPIRE I).
    Fu DJ; Ionescu DF; Li X; Lane R; Lim P; Sanacora G; Hough D; Manji H; Drevets WC; Canuso CM
    J Clin Psychiatry; 2020 May; 81(3):. PubMed ID: 32412700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A systematic review and meta-analysis of the efficacy of ketamine and esketamine on suicidal ideation in treatment-resistant depression.
    Wang YT; Wang XL; Lei L; Guo ZY; Kan FF; Hu D; Gai C; Zhang Y
    Eur J Clin Pharmacol; 2024 Feb; 80(2):287-296. PubMed ID: 38117332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Esketamine Nasal Spray for Rapid Reduction of Depressive Symptoms in Patients With Major Depressive Disorder Who Have Active Suicide Ideation With Intent: Results of a Phase 3, Double-Blind, Randomized Study (ASPIRE II).
    Ionescu DF; Fu DJ; Qiu X; Lane R; Lim P; Kasper S; Hough D; Drevets WC; Manji H; Canuso CM
    Int J Neuropsychopharmacol; 2021 Jan; 24(1):22-31. PubMed ID: 32861217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Repeated Intravenous Esketamine on Adolescents With Major Depressive Disorder and Suicidal Ideation: A Randomized Active-Placebo-Controlled Trial.
    Zhou Y; Lan X; Wang C; Zhang F; Liu H; Fu L; Li W; Ye Y; Hu Z; Chao Z; Ning Y
    J Am Acad Child Adolesc Psychiatry; 2024 May; 63(5):507-518. PubMed ID: 37414272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment-resistant depression patients with baseline suicidal ideation required more treatments to achieve therapeutic response with ketamine/esketamine.
    Singh B; Vande Voort JL; Pazdernik VK; Frye MA; Kung S
    J Affect Disord; 2024 Apr; 351():534-540. PubMed ID: 38302067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The rapid anti-suicidal ideation effect of ketamine: A systematic review.
    Hochschild A; Grunebaum MF; Mann JJ
    Prev Med; 2021 Nov; 152(Pt 1):106524. PubMed ID: 34538369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and Safety of Intranasal Esketamine for the Rapid Reduction of Symptoms of Depression and Suicidality in Patients at Imminent Risk for Suicide: Results of a Double-Blind, Randomized, Placebo-Controlled Study.
    Canuso CM; Singh JB; Fedgchin M; Alphs L; Lane R; Lim P; Pinter C; Hough D; Sanacora G; Manji H; Drevets WC
    Am J Psychiatry; 2018 Jul; 175(7):620-630. PubMed ID: 29656663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy and safety of esketamine in the treatment of major depressive disorder with suicidal ideation: study protocol for a randomized controlled trial.
    Liu H; Lan X; Wang C; Zhang F; Fu L; Li W; Ye Y; Hu Z; Chao Z; Ning Y; Zhou Y
    BMC Psychiatry; 2022 Nov; 22(1):744. PubMed ID: 36451150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ketamine for suicidal ideation in adults with psychiatric disorders: A systematic review and meta-analysis of treatment trials.
    Witt K; Potts J; Hubers A; Grunebaum MF; Murrough JW; Loo C; Cipriani A; Hawton K
    Aust N Z J Psychiatry; 2020 Jan; 54(1):29-45. PubMed ID: 31729893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating the Role of Ketamine/Esketamine in the Management of Major Depressive Disorder with Suicide Risk.
    Nikayin S; Sanacora G
    CNS Drugs; 2021 Oct; 35(10):1069-1079. PubMed ID: 34491545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Commentary on Cochrane review: "Ketamine and other glutamate receptor modulators for depression in adults with unipolar major depressive disorder".
    Borentain S; Desai P; Fu DJ; Nancy Chen L; Lane R; Mathews M; Canuso CM
    J Psychopharmacol; 2023 Aug; 37(8):836-844. PubMed ID: 36218274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Esketamine Nasal Spray for the Rapid Reduction of Depressive Symptoms in Major Depressive Disorder With Acute Suicidal Ideation or Behavior.
    Canuso CM; Ionescu DF; Li X; Qiu X; Lane R; Turkoz I; Nash AI; Lopena TJ; Fu DJ
    J Clin Psychopharmacol; 2021 Sep-Oct 01; 41(5):516-524. PubMed ID: 34412104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute Effects of Intravenous Sub-Anesthetic Doses of Ketamine and Intranasal Inhaled Esketamine on Suicidal Ideation: A Systematic Review and Meta-Analysis.
    Chen CC; Zhou N; Hu N; Feng JG; Wang XB
    Neuropsychiatr Dis Treat; 2023; 19():587-599. PubMed ID: 36942150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The acute antisuicidal effects of single-dose intravenous ketamine and intranasal esketamine in individuals with major depression and bipolar disorders: A systematic review and meta-analysis.
    Xiong J; Lipsitz O; Chen-Li D; Rosenblat JD; Rodrigues NB; Carvalho I; Lui LMW; Gill H; Narsi F; Mansur RB; Lee Y; McIntyre RS
    J Psychiatr Res; 2021 Feb; 134():57-68. PubMed ID: 33360864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Randomized, Double-Blind, Midazolam-Controlled Trial of Low-Dose Ketamine Infusion in Patients With Treatment-Resistant Depression and Prominent Suicidal Ideation.
    Su TP; Li CT; Lin WC; Wu HJ; Tsai SJ; Bai YM; Mao WC; Tu PC; Chen LF; Li WC; Chen MH
    Int J Neuropsychopharmacol; 2023 May; 26(5):331-339. PubMed ID: 36966411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repeat-dose ketamine augmentation for treatment-resistant depression with chronic suicidal ideation: A randomized, double blind, placebo controlled trial.
    Ionescu DF; Bentley KH; Eikermann M; Taylor N; Akeju O; Swee MB; Pavone KJ; Petrie SR; Dording C; Mischoulon D; Alpert JE; Brown EN; Baer L; Nock MK; Fava M; Cusin C
    J Affect Disord; 2019 Jan; 243():516-524. PubMed ID: 30286416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Randomized, Double-Blind, Placebo-Controlled Pilot Trial of the Acute Antisuicidal and Antidepressant Effects of Intranasal (R,S)-Ketamine in Severe Unipolar and Bipolar Depression With and Without Comorbid Alcohol Use Disorder.
    Jones GH; Vecera CM; Ruiz AC; Wu HE; McInturff SI; Orejarena MJ; Smith KA; Soares JC; Zarate CA; Lane SD; Machado-Vieira R
    J Clin Psychiatry; 2024 Apr; 85(2):. PubMed ID: 38696221
    [No Abstract]   [Full Text] [Related]  

  • 19. Ketamine for treatment of mood disorders and suicidality: A narrative review of recent progress.
    Kritzer MD; Mischel NA; Young JR; Lai CS; Masand PS; Szabo ST; Mathew SJ
    Ann Clin Psychiatry; 2022 Feb; 34(1):33-43. PubMed ID: 35166663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. (Es)Ketamine for Suicidal Ideation and Behavior: Clinical Efficacy.
    Alario AA; Niciu MJ
    Chronic Stress (Thousand Oaks); 2022; 6():24705470221128017. PubMed ID: 36276228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.